Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SPHL | Springview | $8.52 | -$8.89 | -51.06% | 2.9M | $203M | $1.92$62.40 |
| THH | TryHard | $4.07 | -$3.53 | -46.45% | 2M | $380M | $4.00$55.05 |
| ANPA | Hong Kong Prosperous Sheep | $99.88 | -$58.02 | -36.74% | 70.8K | $2.0B | $2.80$180.64 |
| MLEC | Moolec Science | $5.21 | -$2.49 | -32.34% | 416.3K | $5.6M | $3.08$157.05 |
| RAYA | Erayak Power Solution Group | $2.82 | -$1.11 | -28.18% | 387.9K | $3.5M | $2.75$737.00 |
| PAVM | PAVmed | $6.31 | -$2.44 | -27.89% | 59.7K | $9.3M | $6.00$26.85 |
| CJMB | Callan Jmb | $3.51 | -$0.69 | -16.43% | 3.9M | - | $1.08$7.76 |
| BNKK | Bonk | $3.31 | -$0.65 | -16.41% | 1.2M | $21M | $2.33$46.90 |
| SMCZ | Tidal Trust II - Defiance Daily Target 2x Short Smci ETF | $46.35 | -$8.82 | -15.98% | 340.5K | - | $19.85$225.57 |
| ABUS | Arbutus Biopharma | $3.99 | -$0.72 | -15.21% | 5.5M | $904M | $2.71$5.10 |
Related Articles
Featured Article
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
Keith Speights|Aug 25, 2024
The dividend yields for these stocks are tempting. But some temptations should be avoided.
These 3 Dividend Stocks Yield Investors 9.6% or More. Here's Which 1 I'd Buy First.
Courtney Carlsen|Dec 6, 2023
High-yielding dividend stocks can be an excellent source of passive income but come with added risks.
Why Is B. Riley Financial's Dividend So High?
Courtney Carlsen|May 24, 2023
This stock yields nearly 11%. Is it sustainable?
Advertisement
Is B. Riley the Next Berkshire Hathaway?
Michael Byrne|Mar 24, 2022
The diversified financial-services platform is building an operation that Buffett would endorse.
3 Reasons Why B. Riley Looks Like a Strong Buy
Michael Byrne|Mar 17, 2022
This high-yielding stock should be on your radar.
What's the Outlook for Arbutus Biopharma?
Keith Speights and Brian Orelli, PhD|Feb 5, 2022
The company could have great prospects if its hepatitis B virus therapy is successful in clinical testing.
Wall Street Is Missing Out on This Dirt Cheap Stock
Courtney Carlsen|Nov 17, 2021
Sometimes stocks that trade at cheap valuations can be a trap. This isn't one of them.
Insiders Can't Stop Buying This Value Stock
Courtney Carlsen|Jul 12, 2021
This financial services provider's co-CEO has spent $10 million buying stock since November. Should you consider it too?
3 Healthcare Stocks That Rocketed Higher in July
Cory Renauer|Aug 3, 2020
Here's what drove shares of these healthcare stocks through the roof last month.
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
Taylor Carmichael|Jul 24, 2020
The ruling means Moderna may have to pay royalties on its mRNA-based vaccines -- including its coronavirus candidate.
